Phibro Animal Health (PAHC) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Phibro Animal Health Corporation Reports Third Quarter Results
May 7, 2020 4:40 PM EDTTEANECK, N.J.--(BUSINESS WIRE)-- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2020.
Highlights for the March 2020 quarter (compared to the March 2019 quarter)
Net sales of $211 million, an increase of $5 million, or 2% Net income of $14 million, a decrease of $1 million, or 9% Diluted EPS of $0.33, a decrease of $0.04, or 11% Adjusted EBITDA of $30 million, comparable to the prior year quarter Adjusted diluted EPS of $0.38, a decrease of $0.01, or 3%COMMENTARY
"The... More
